project id: TCGA-BRCA; case submitter id: TCGA-BH-A8FY; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.44; rna integrity number: 9.2; age at index: 87; days to birth: -31932; days to death: 295; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1925; year of death: 2012; age at diagnosis: 31932; ajcc pathologic m: M0; ajcc pathologic n: N0 (i+); ajcc pathologic stage: Stage IA; ajcc pathologic t: T1c; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 477; initial weight: 200.0; sample id: 8063e0be-03ea-4a66-8592-dbb2d9f49045; sample submitter id: TCGA-BH-A8FY-01A; portion id: 8675e831-982f-4c88-933f-69b6aa6c1d75; portion submitter id: TCGA-BH-A8FY-01A-11; slide id: d4e0e11f-b9fb-4e9d-9f4d-5773a3077f9b; slide submitter id: TCGA-BH-A8FY-01A-01-TSA; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; section location: TOP;